| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 03/06/2007 | US7186713 Farnesyl dibenzodiazepinones and methods of treating cancer using same |
| 03/06/2007 | US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/06/2007 | US7186277 hair dyes with improved colorfastness, washfastness, photostability, color uniformity and tinctorial strength |
| 03/01/2007 | WO2007023273A1 Cell migration modulating compounds |
| 03/01/2007 | WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | WO2006117672A3 Detection of ortho-diamine residues in analytes containing residual cyclizing agents |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049580 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 02/28/2007 | EP1756070A2 Crystalline forms of n-desmethylclozapine |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/22/2007 | US20070043033 Unsolvated benzodiazepine compositions and methods |
| 02/22/2007 | US20070043029 11-Phenyl-dibenzodiazepine derivatives as rxr-antagonists |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1753766A1 Tetraazabenzo(e)azulene derivatives and analogs thereof |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/13/2007 | US7176306 Hydroxyalkyl cyclic diamine compound |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/08/2007 | WO2006071775A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 02/07/2007 | EP1749824A1 Benzodiazepine derivatives, their preparation and the therapeutic use thereof |
| 02/07/2007 | EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2007 | CN1910137A Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/01/2007 | US20070027143 Novel substituted 2,3-benzodiazepine derivatives |
| 02/01/2007 | US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 02/01/2007 | US20070027132 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/25/2007 | WO2006089298A3 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/23/2007 | US7166587 Gamma -secretase inhibitors; for treatment of Alzheimer's disease; e.g 2,3-difluoro-benzyl)-carbamic acid (S)-1-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-ylcarbamoyl)-ethyl ester |
| 01/18/2007 | WO2006102176A3 Process for preparing crystalline form i of olanzapine |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1537117B1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
| 01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
| 01/17/2007 | CN1898217A Benzo'1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 01/11/2007 | WO2006020959A3 Substituted benzofused heterocycles |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/10/2007 | EP1740185A1 Benzodiazepines for treating or preventing rsv infection |
| 01/10/2007 | CN1894217A Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 01/10/2007 | CN1294134C Cyclohexylphenyl vasopression agonists |
| 01/09/2007 | US7160880 Producing sedation, hypnosis, inducing anxiolysis, muscle relaxation; treating convulsions; CNS depressants; pharmacodynamic |
| 01/09/2007 | US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| 01/09/2007 | US7160878 Substituted heterocyclic amides |
| 01/09/2007 | US7160875 Malonamide derivatives |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | CA2266444C Olanzapine dihydrate d |
| 12/28/2006 | WO2006136564A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/26/2006 | US7153850 Lactam compounds and pharmaceutical use thereof |
| 12/26/2006 | US7153849 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder |
| 12/21/2006 | WO2006104997A3 Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor |
| 12/21/2006 | WO2006012130A3 Polyproplene grids manufactured with a beta nucleation additive, the method of manufacture and uses thereof |
| 12/21/2006 | US20060287294 Aspartyl protease inhibitors |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/20/2006 | EP1733758A1 Methods for administration of a farnesyl dibenzodiazepinone |
| 12/20/2006 | CN1882551A Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1290500C Retroviral protease inhibitor combinations |
| 12/19/2006 | US7151098 Glutamate receptor antagonists |
| 12/14/2006 | US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease |
| 12/13/2006 | EP1730117A2 Thiourea compositions and uses thereof |
| 12/12/2006 | US7148238 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]piperidine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 12/12/2006 | CA2245926C 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them |
| 12/07/2006 | US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
| 12/06/2006 | CN1875005A Malonamide derivatives blocking the activtiy of gamma-secretase |
| 12/06/2006 | CN1872854A Antibiotic in lactam class, and prepartion method |
| 12/05/2006 | US7144884 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 12/05/2006 | US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders |
| 12/05/2006 | US7144880 Compositions relating to novel compounds and targets thereof |
| 11/29/2006 | EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia |
| 11/29/2006 | EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 11/29/2006 | CN1871223A 8-chloro-2,3-benzodiazepine derivatives |
| 11/28/2006 | US7141563 Used for prophylaxis and therapy of central nervous system disorders, including obsessive-compulsive disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, panic disorder, migraine, sleep disorders |
| 11/28/2006 | US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments |
| 11/23/2006 | WO2006084870A3 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/23/2006 | US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer |
| 11/23/2006 | US20060264417 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease |
| 11/22/2006 | EP1723955A1 Medicine for prevention and/or treatment of ischemic circulatory disease |
| 11/22/2006 | EP1351933B1 Il-8 receptor antagonists |
| 11/21/2006 | US7138407 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 11/21/2006 | CA2511750C Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals |
| 11/21/2006 | CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 11/16/2006 | WO2006088541A3 Quinoline derivatives and uses thereof |
| 11/16/2006 | US20060258638 Succinoylamino lactams as inhibitors of A-beta protein production |
| 11/15/2006 | EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 11/15/2006 | CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent |